Cargando…

Frequency of Exacerbations in COPD: An Analysis of the SPIROMICS Cohort

BACKGROUND: Current treatment strategies to stratify exacerbation risk rely on history of ≥2 events in the previous year. To understand year-to-year variability and factors associated with consistent exacerbations over time, we present a prospective analysis of the SPIROMICS cohort. METHODS: We anal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, MeiLan K., Quibrera, Pedro M, Carretta, Elizabeth E., Barr, R. Graham, Bleecker, Eugene R, Bowler, Russell P., Cooper, Christopher B, Comellas, Alejandro, Couper, David J., Curtis, Jeffrey L., Criner, Gerard, Dransfield, Mark T, Hansel, Nadia N., Hoffman, Eric A., Kanner, Richard E., Krishnan, Jerry A., Martinez, Carlos H., Pirozzi, Cheryl B., O’Neal, Wanda K., Rennard, Stephen, Tashkin, Donald P., Wedzicha, Jadwiga A., Woodruff, Prescott, Paine, Robert, Martinez, Fernando J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558856/ https://www.ncbi.nlm.nih.gov/pubmed/28668356 http://dx.doi.org/10.1016/S2213-2600(17)30207-2

Ejemplares similares

Novel Respiratory Disability Score Predicts COPD Exacerbations and Mortality in the SPIROMICS Cohort
por: Cooper, Christopher B, et al.
Publicado: (2020)

Lower serum IgA is associated with COPD exacerbation risk in SPIROMICS
por: Putcha, Nirupama, et al.
Publicado: (2018)

Design of the Subpopulations and Intermediate Outcome Measures in COPD (SPIROMICS) AIR Study
por: Hansel, Nadia N, et al.
Publicado: (2017)

Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis
por: Barjaktarevic, Igor Z, et al.
Publicado: (2019)

Sputum or blood eosinophil association with clinical measures of COPD severity in the SPIROMICS cohort
por: Hastie, AT, et al.
Publicado: (2017)

Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort
por: Opron, Kristopher, et al.
Publicado: (2021)

Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS Cohort
por: Stott-Miller, Marni, et al.
Publicado: (2020)

Longitudinal Imaging-Based Clusters in Former Smokers of the COPD Cohort Associate with Clinical Characteristics: The SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)
por: Zou, Chunrui, et al.
Publicado: (2021)

Imaging-based clusters in current smokers of the COPD cohort associate with clinical characteristics: the SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)
por: Haghighi, Babak, et al.
Publicado: (2018)

Imaging-based clusters in former smokers of the COPD cohort associate with clinical characteristics: the SubPopulations and intermediate outcome measures in COPD study (SPIROMICS)
por: Haghighi, Babak, et al.
Publicado: (2019)

Serum amino acid concentrations and clinical outcomes in smokers: SPIROMICS metabolomics study
por: Labaki, Wassim W., et al.
Publicado: (2019)

Comparison of serum, EDTA plasma and P100 plasma for luminex-based biomarker multiplex assays in patients with chronic obstructive pulmonary disease in the SPIROMICS study
por: O’Neal, Wanda K, et al.
Publicado: (2014)

Increased airway iron parameters and risk for exacerbation in COPD: an analysis from SPIROMICS
por: Zhang, William Z., et al.
Publicado: (2020)

Association of plasma mitochondrial DNA with COPD severity and progression in the SPIROMICS cohort
por: Zhang, William Z., et al.
Publicado: (2021)

Black carbon content in airway macrophages is associated with increased severe exacerbations and worse COPD morbidity in SPIROMICS
por: Tejwani, Vickram, et al.
Publicado: (2022)

Association of thrombocytosis with COPD morbidity: the SPIROMICS and COPDGene cohorts
por: Fawzy, Ashraf, et al.
Publicado: (2018)

Design of a multi-center immunophenotyping analysis of peripheral blood, sputum and bronchoalveolar lavage fluid in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)
por: Freeman, Christine M, et al.
Publicado: (2015)

Variability in objective and subjective measures affects baseline values in studies of patients with COPD
por: Anderson, Wayne H., et al.
Publicado: (2017)

Centrilobular emphysema and coronary artery calcification: mediation analysis in the SPIROMICS cohort
por: Bhatt, Surya P., et al.
Publicado: (2018)

The influence of social support on COPD outcomes mediated by depression
por: Turnier, Leonard, et al.
Publicado: (2021)

Heterogeneous burden of lung disease in smokers with borderline airflow obstruction
por: Pirozzi, Cheryl S., et al.
Publicado: (2018)

Latent traits of lung tissue patterns in former smokers derived by dual channel deep learning in computed tomography images
por: Li, Frank, et al.
Publicado: (2021)

The matrikine acetyl-proline-glycine-proline and clinical features of COPD: findings from SPIROMICS
por: Wells, J. Michael, et al.
Publicado: (2019)

Correcting Nonpathological Variation in Longitudinal Parametric Response Maps of CT Scans in COPD Subjects: SPIROMICS
por: Fernández-Baldera, Antonio, et al.
Publicado: (2017)

Current smoking with or without chronic bronchitis is independently associated with goblet cell hyperplasia in healthy smokers and COPD subjects
por: Kim, Victor, et al.
Publicado: (2020)

Genome-wide association study of lung function and clinical implication in heavy smokers
por: Li, Xingnan, et al.
Publicado: (2018)

Differentiation of quantitative CT imaging phenotypes in asthma versus COPD
por: Choi, Sanghun, et al.
Publicado: (2017)

Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD
por: Sun, Wei, et al.
Publicado: (2016)

Machine learning for screening of at-risk, mild and moderate COPD patients at risk of FEV(1) decline: results from COPDGene and SPIROMICS
por: Wang, Jennifer M., et al.
Publicado: (2023)

A blood and bronchoalveolar lavage protein signature of rapid FEV(1) decline in smoking-associated COPD
por: DiLillo, Katarina M., et al.
Publicado: (2023)

Robust Measures of Image-Registration-Derived Lung Biomechanics in SPIROMICS
por: Pan, Yue, et al.
Publicado: (2022)

An airway epithelial IL-17A response signature identifies a steroid-unresponsive COPD patient subgroup
por: Christenson, Stephanie A., et al.
Publicado: (2018)

The association of plasma biomarkers with computed tomography-assessed emphysema phenotypes
por: Carolan, Brendan J, et al.
Publicado: (2014)

Bronchoalveolar Lavage Fluid from COPD Patients Reveals More Compounds Associated with Disease than Matched Plasma
por: Halper-Stromberg, Eitan, et al.
Publicado: (2019)

Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis [Corrigendum]
Publicado: (2020)

From GOLD 0 to Pre-COPD
por: Han, MeiLan K., et al.
Publicado: (2021)

Reply to Thomson, to Neder et al., and to Wouters
por: Han, MeiLan K., et al.
Publicado: (2021)

The value of blood cytokines and chemokines in assessing COPD
por: Bradford, Eric, et al.
Publicado: (2017)

Effect of Naturally Occurring Ozone Air Pollution Episodes on Pulmonary Oxidative Stress and Inflammation
por: Pirozzi, Cheryl, et al.
Publicado: (2015)

Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium
por: Kasela, Silva, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n8o7d6t52ufge9a2uldmheruc8